Our research focus is on understanding mechanisms of drug resistance in lung cancer. We have a particular focus on EGFR-mutant lung cancer and trying to understand the biology of drug-tolerant persister cells. We use a variety of different approahces in the lab including phosphoproteomics, transcriptomics, biochemistry, and mouse models. Our ultimate goal is to identify drug targets that we can translate into the clinic.